<VariationArchive VariationID="2637862" VariationName="NC_000010.10:g.(131676114_131755521)_(131762539_?)del" VariationType="Deletion" Accession="VCV002637862" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2023-11-20" MostRecentSubmission="2023-11-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2805339" VariationID="2637862">
      <GeneList>
        <Gene Symbol="EBF3" FullName="EBF transcription factor 3" GeneID="253738" HGNC_ID="HGNC:19087" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>10q26.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="129835233" stop="129964274" display_start="129835233" display_stop="129964274" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="131633495" stop="131762090" display_start="131633495" display_stop="131762090" Strand="-" />
          </Location>
          <OMIM>607407</OMIM>
          <Haploinsufficiency last_evaluated="2023-12-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EBF3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-12-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EBF3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000010.10:g.(131676114_131755521)_(131762539_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>10q26.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" outerStart="131676114" innerStart="131755521" innerStop="131762539" display_start="131676114" display_stop="131762539" variantLength="86426" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.(131676114_131755521)_(131762539_?)del" Assembly="GRCh37">
            <Expression>NC_000010.10:g.(131676114_131755521)_(131762539_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000010.10:g.(131676114_131755521)_(131762539_?)del AND Hypotonia, ataxia, and delayed development syndrome" Accession="RCV003405160" Version="1">
        <ClassifiedConditionList TraitSetID="34985">
          <ClassifiedCondition DB="MedGen" ID="C4310618">Hypotonia, ataxia, and delayed development syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-23" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-11-20" MostRecentSubmission="2023-11-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="34985" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36858" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypotonia, ataxia, and delayed development syndrome</ElementValue>
                <XRef ID="MONDO:0015021" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HADDS</ElementValue>
                <XRef Type="MIM" ID="617330" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">EBF3 neurodevelopmental disorder (EBF3-NDD) is associated with developmental delay (DD) / intellectual disability (ID), speech delay, gait or truncal ataxia, hypotonia, behavioral problems, and facial dysmorphism. Variability between individuals with EBF3-NDD is significant. Although all affected children have DD noted in early infancy, intellect generally ranges from mild to severe ID, with two individuals functioning in the low normal range. Less common issues can include genitourinary abnormalities and gastrointestinal and/or musculoskeletal involvement. To date, 42 symptomatic individuals from 39 families have been reported.</Attribute>
                <XRef ID="NBK570204" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33956416</ID>
                <ID Source="BookShelf">NBK570204</ID>
              </Citation>
              <XRef ID="658843" DB="Orphanet" />
              <XRef ID="C4310618" DB="MedGen" />
              <XRef ID="MONDO:0015021" DB="MONDO" />
              <XRef Type="MIM" ID="617330" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7702958" SubmissionDate="2023-11-14" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="NC_000010.10:g.(131676114_131755521)_(131762539_?)del|MedGen:C4310618" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004122004" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Variant summary: The variant identified by MLPA or other technology involves the deletion of exons 1-6 in the EBF3 gene, where exon 1 contains the translation initiation codon. The exact breakpoint at the 5' end of this variant is unknown and therefore this deletion might extend upstream of the assayed region of the gene. A presumed nomenclature of c.(?_-507)_(554+1_555-1)del has been designated for the purposes of this classification. Although exact breakpoints of this deletion are not known, it is expected to result in an absent or shortened protein product, a known mechanism of disease. The variant was absent in 21694 control chromosomes (gnomAD Structural Variants dataset). To our knowledge, no occurrence of c.(?_-507)_(554+1_555-1)del in individuals affected with Hypotonia, Ataxia, And Delayed Development Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. However, several in-frame variants are reported in the deleted region in individuals affected with hypotonia, ataxia, and delayed development syndrome (HGMD). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EBF3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.(131676114_131755521)_(131762539_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4310618" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13972740</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7702958" TraitType="Disease" MappingType="XRef" MappingValue="C4310618" MappingRef="MedGen">
        <MedGen CUI="C4310618" Name="Hypotonia, ataxia, and delayed development syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

